CovidVax show full list

Multitope Peptide-Based Vaccine (MVP)

Covaxx + University of Nebraska Medical Center (UNMC) + DASA
vaccine type: Protein subunit
Distribution updates
Jul 15Covaxx MPV vaccine will start human trials in September hoping to produce 100M doses by Q1 2021 (by
Human Testing updates (clinical trials)



started September 1 2020

with 60 healthy volunteers aged 20-55

trial location: Taiwan

» clinical trial details

Feb 02On Jan.29 Taiwan Ministry of Health and Welfare granted conditional approval to begin Phase 2 trials of COVAXX vaccine (by
Sep 28COVAXX announced today the first healthy adult volunteers were safely dosed in the company Phase 1 trial in Taiwan (by
Sep 11UNMC has signed an agreement with COVAXX to conduct clinical trials using COVAXX-created therapeutics (by
Sep 09Dasa and COVAXX have signed a letter of intent to work together to conduct clinical trials in Brazil (by
Jul 15Covaxx is developing the first MPV covid-19 vaccine and will enter human trials next month (by
Animal Testing updates (pre-clinical trials)
Jul 15Covaxx has tested more than 30 vaccine candidate constructs in animals from March to May 2020 (by
Jul 01Data from Covaxx's preclinical studies showed the highest immunogenicity against live virus (by
early development updates
currently no early development info

contact | about | ©2020 project